Apr 26, 2016 ... Gilead Sciences (GILD), which is set to report first-quarter 2016 results on ...
Gilead's blockbuster hepatitis C virus (HCV) drug Harvoni should ... Here are a
couple of other health care stocks that you may want to ... Biotech Stock Roundup
: Biogen Q2 Results Impress, Gilead HCV Franchise Under Pressure.
Jun 8, 2016 ... Late Tuesday, Gilead Sciences (GILD) won a court ruling in its battle with Merck
... property rights behind its blockbuster hepatitis-C drugs Harvoni and Sovaldi. ...
News and commentary about the stocks you need to know about today ... 2016
but generated only $50 million of sales in the first quarter of 2016.
Apr 29, 2016 ... Gilead Sciences, Inc.'s GILD first-quarter 2016 earnings (including ... Gilead's
blockbuster hepatitis C virus (HCV) drug, Harvoni, plunged ..... Apple Car rumor
roundup: Here's everything you need to know about 'Project Titan'.
May 4, 2016 ... Big names in the biotech sector reported earnings over the last five trading days
... Vertex's first quarter results were also disappointing with the ... According to
AbbVie, the candidate has blockbuster potential and could ..... Apple Car rumor
roundup: Here's everything you need to know about 'Project Tita...
May 10, 2014 ... Gilead's windfall is no doubt figuring into AbbVie's strategy for how it introduces
its own treatment in the fourth quarter. ... “When you look at the attributes of this
product, the performance speaks for itself,” he told analysts in January. ... the
rheumatoid arthritis blockbuster that starts going off patent...
1 day ago ... 5 Reasons You Should Be a Long-Term Investor ... Biotech Stock Roundup: Q2
Earnings Beats ... second quarter results over the last few days - Biogen and
Gilead. ... of the label of its blockbuster drug, Revlimid, as maintenance treatment
in a ... Today, you can download 7 Best Stocks for the Next 30 Days.
Feb 10, 2015 ... Read on and see if you agree with my slap and tickle math. ... what Hammergren
disclosed during McKesson's October 2014 earnings call: ... In McKesson's
second 2015 fiscal quarter (2014's third calendar ... Consider Gilead Sciences'
Sovaldi, the hepatitis C drug approved in ..... Weekly Roundup 7.22.16.
2 days ago ... Regulatory Recon: Baxter, Lilly Beat Sales Estimates; Gilead Lowers ... (STAT);
Gilead Readying for Earnings Report , Lowers 2016 Guidance Amid Slowing ...
use among Medicaid children with asthma (Health Marketing Quarterly) ... Each
weekday morning, we aim to bring you the latest highlights of new ...
Jul 9, 2012 ... These factors could hold the key to big gains with Gilead Sciences. ... $1.84
billion of Gilead's $2.21 billion in net product sales in the first-quarter. ... Just in
case you weren't aware, the race to create the next blockbuster ... Foolish
roundup. Now that you know what to watch for, it should be easier to an...
Apr 29, 2016 ... Health Policy Research; Research Roundup: New Medicare Doc Pay; ... Keep in
mind that we give extra points if you link back to a KHN original story. ..... Aetna's
first-quarter earnings slid nearly 7 percent as enrollment ... The drugmaker Gilead
Sciences has seen its fortunes buoyed by its blockbuster ...